Raymond James & Associates’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,565
Closed -$317K 4086
2022
Q2
$317K Sell
11,565
-551
-5% -$16.3K ﹤0.01% 3195
2022
Q1
$457K Buy
12,116
+2,111
+21% +$93.4K ﹤0.01% 3122
2021
Q4
$621K Buy
10,005
+508
+5% +$38.5K ﹤0.01% 2929
2021
Q3
$812K Sell
9,497
-3,540
-27% -$222K ﹤0.01% 2718
2021
Q2
$807K Sell
13,037
-72
-0.5% -$3.66K ﹤0.01% 2734
2021
Q1
$639K Buy
13,109
+3,085
+31% +$149K ﹤0.01% 2827
2020
Q4
$312K Sell
10,024
-740
-7% -$18.1K ﹤0.01% 3101
2020
Q3
$224K Buy
+10,764
New +$185K ﹤0.01% 3140

Other funds holding OPRX